Epitope‐specific affinity maturation improved stability of potent protease inhibitory antibodies-Reference-Cited by-同舟云学术

Epitope‐specific affinity maturation improved stability of potent protease inhibitory antibodies

Published:2018-09-15 Issue:11 Volume:115 Page:2673-2682
ISSN:0006-3592
Container-title:Biotechnology and Bioengineering
language:en
Short-container-title:Biotechnology and Bioengineering

Author:

Lopez Tyler¹,Chuan Chen¹,Ramirez Aaron¹,Chen Kuan‐Hui E.²,Lorenson Mary Y.²,Benitez Chris¹,Mustafa Zahid¹,Pham Henry¹,Sanchez Ramon¹,Walker Ameae M.²,Ge Xin¹^ORCID

Affiliation:

1. Department of Chemical and Environmental Engineering Bourns College of Engineering, University of California Riverside Riverside California

2. Division of Biomedical Sciences School of Medicine University of California Riverside Riverside California

Funder

National Science Foundation

National Institutes of Health

Publisher

Wiley

Subject

Applied Microbiology and Biotechnology,Bioengineering,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/bit.26814

Reference51 articles.

1. Blockade of MMP14 Activity in Murine Breast Carcinomas: Implications for Macrophages, Vessels, and Radiotherapy

2. Biochemical characterization and structure determination of a potent, selective antibody inhibitor of human MMP9

3. [25] Yeast surface display for directed evolution of protein expression, affinity, and stability

4. Calculation of inhibitor Ki and inhibitor type from the concentration of inhibitor for 50% inhibition for Michaelis-Menten enzymes

5. Monoclonal antibody therapeutics: history and future

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protease Inhibition Mechanism of Camelid-like Synthetic Human Antibodies;Biochemistry;2020-09-30

2. Functional selection of protease inhibitory antibodies;Proceedings of the National Academy of Sciences;2019-07-30

3. Inhibitory Antibodies Designed for Matrix Metalloproteinase Modulation;Molecules;2019-06-18

4. Selectivity Conversion of Protease Inhibitory Antibodies;Antibody Therapeutics;2018-09